Arena Pharmaceuticals Inc (ARNA) President and CEO Amit Munshi Sold $8 million of Shares

Author's Avatar
GuruFocus News
01/20/2021 21:15
Article's Main Image

President and CEO of Arena Pharmaceuticals Inc (30-Year Financial, Insider Trades) Amit Munshi (insider trades) sold 100,000 shares of ARNA on 01/19/2021 at an average price of $80.19 a share. The total sale was $8 million.

Arena Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. Arena Pharmaceuticals Inc has a market cap of $4.72 billion; its shares were traded at around $81.220000 with and P/S ratio of 1289.19. GuruFocus has detected 3 severe warning signs with Arena Pharmaceuticals Inc. .

CEO Recent Trades:

  • President and CEO Amit Munshi sold 100,000 shares of ARNA stock on 01/19/2021 at the average price of $80.19. The price of the stock has increased by 1.28% since.
  • President and CEO Amit Munshi sold 14,877 shares of ARNA stock on 01/12/2021 at the average price of $75.12. The price of the stock has increased by 8.12% since.

Directors and Officers Recent Trades:

  • Director Jayson Donald Alexander Dallas sold 1,327 shares of ARNA stock on 01/19/2021 at the average price of $80.5. The price of the stock has increased by 0.89% since.

For the complete insider trading history of ARNA, click here

.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].